The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Roche
TALENTACE: A phase III, open-label, randomized study of on-demand transarterial chemoembolization combined with atezolizumab + bevacizumab or on-demand transarterial chemoembolization alone in patients with untreated hepatocellular carcinoma.
 
Masatoshi Kudo
Honoraria - Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Lilly Japan; MSD
Consulting or Advisory Role - BMS; Eisai; MSD; Ono Pharmaceutical; Roche
Research Funding - Abbvie (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Ono Pharmaceutical; Otsuka (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Yabing Guo
No Relationships to Disclose
 
Yongqiang Hua
No Relationships to Disclose
 
Ming Zhao
No Relationships to Disclose
 
Wenge Xing
No Relationships to Disclose
 
Yonghong Zhang
No Relationships to Disclose
 
Ruibao Liu
No Relationships to Disclose
 
Zhenggang Ren
No Relationships to Disclose
 
Shanzhi Gu
No Relationships to Disclose
 
Zhengyu Lin
No Relationships to Disclose
 
Weifu Lv
No Relationships to Disclose
 
Yumeng Wang
Employment - Roche
 
Jiahong Dong
No Relationships to Disclose